GSTP1 and chromophobe renal cell carcinoma: Finally, when the combined effect of all four GST genotypes was analyzed, we found striking evidence in favor of increased susceptibility to cRCC in patients with, what it seems to be, “risk carrying genotype combination”: GSTM1-null, GSTT1-active, GSTA1 low-activity and GSTP1-variant.